跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Zynapse
Approved
STANDARD
Zynapse
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
856a389e6e7db1c3
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
856a389e6e7db1c3
Drug Approval Philippines Name
Zynapse
Product Name
Zynapse
Registration Number
DRP-432-01
Brand Name
Zynapse
Generic Name
Citicoline
Dosage Form
Capsule
Dosage Strength
500mg
Manufacturer
Hizon Laboratories, Inc.
Trader
Patriot Pharmaceuticals Corporation
Distributor
Natrapharm, Inc.
Issuance Date
28 March 2023
Expiry Date
24 June 2028
Pharmacologic Category
Psychostimulant/Nootropic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
856a389e6e7db1c3
Type
Standard
Back to Philippines FDA Approvals
Zynapse - Philippines FDA Drug Approval Details